CONSTELLATION PHARMACEUTICALS INC: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2020)
- -$126.4M
- Total Assets (FY2020)
- $441.9M
- Total Equity (FY2020)
- $410.7M
- Cash Flows from Operating Activities (FY2020)
- -$111.4M
Source: CONSTELLATION PHARMACEUTICALS INC 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
